Au M K, Singh P
Department of Ophthalmology, Faculty of Medicine, National University of Malaysia, Kuala Lumpur.
Med J Malaysia. 1991 Dec;46(4):329-32.
The effect of an antiprostaglandin, piroxicam, in preventing surgically induced miosis is studied. Patients undergoing extracapsular cataract surgery were randomly divided into the piroxicam and placebo groups. Intra-operative measurements of the pupillary diameters were performed. The stages of procedure at which they were measured were at the beginning of operation (Stage 1), after anterior capsulotomy (Stage 2), after lens nucleus delivery (Stage 3) and at the end of irrigation and aspiration (Stage 4). It is noted in this Study that the pupillary diameters were larger at stages 2,3 and 4 in the piroxicam group. The increase in the mean pupillary areas of the piroxicam group were statistically significant for Stages 3 and 4.
研究了一种抗前列腺素药物吡罗昔康预防手术引起瞳孔缩小的效果。接受白内障囊外摘除术的患者被随机分为吡罗昔康组和安慰剂组。术中测量瞳孔直径。测量瞳孔直径的手术阶段分别为手术开始时(阶段1)、前囊切开术后(阶段2)、晶状体核取出后(阶段3)以及冲洗吸出结束时(阶段4)。本研究发现,吡罗昔康组在阶段2、3和4时的瞳孔直径较大。吡罗昔康组平均瞳孔面积在阶段3和4的增加具有统计学意义。